K. Young

First name
K.
Middle name
G.
Last name
Young
Güdemann, L. M., Young, K. G., Thomas, N. J. M., Hopkins, R. ., Challen, R. ., Jones, A. G., … McGovern, A. P. (2024). Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach. Diabetologia. http://doi.org/10.1007/s00125-024-06190-9
Hopkins, R. ., Young, K. G., Thomas, N. J., Godwin, J. ., Raja, D. ., Mateen, B. A., … Dennis, J. M. (2024). Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study. BMJ Open, 14, e078135. http://doi.org/10.1136/bmjopen-2023-078135
Dennis, J. M., Young, K. G., McGovern, A. P., Mateen, B. A., Vollmer, S. J., Simpson, M. D., … Shields, B. M. (2022). Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study. Lancet Digit Health, 4, e873-e883. http://doi.org/10.1016/s2589-7500(22)00174-1